Oystershell is a world-class developer of innovative consumer healthcare products and is especially acknowledged for its capabilities in the anti-lice and insects category, its new skin treatments such as for warts and several other important contributions to OTC pharma. The innovative product portfolio combines own brands in US and Europe with regional distribution agreements with major OTC players.
Strong R&D platform bringing proven innovations with solid commercialization platform. Acceleration of the execution of its growth strategy including increased focus on R&D and new product launches, international expansion and commercialization of the product portfolio. Growing the platform by means of add-on acquisitions into new treatment areas and geographies
“It’s great to have Rivean on board as a shareholder of Oystershell. Together, we have defined a clear vision and strategic roadmap for our company. And by sharing their best practices and expertise, we have been able to upgrade our company to a significant higher level. In addition, it’s always fun to work with this nice and smart Rivean team“